Clémence Basse
Impact in
-
- COVID-19 and healthcare impacts
-
- Myasthenia Gravis and Thymoma
- Neuroblastoma Research and Treatments
Papers in
- Oncology 13
- Lung Cancer Research Studies 4
- COVID-19 and healthcare impacts 3
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Michel Arock (1 shared paper)Nicolas Girard (17 shared papers)Keith Killian (1 shared paper)Jeffrey S. Ross (1 shared paper)Shakti Ramkissoon (1 shared paper)Xavier Paolettí (2 shared papers)Alexa B. Schrock (1 shared paper)Laurence Bozec (2 shared papers)
- Journals
- Lung Cancer (5 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)Clinical Lung Cancer (2 papers)The Oncologist (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Clémence Basse
26 papers receiving 265 citations
Peers
Comparison fields: 5 of 50
- Oncology 126
- Neurology 47
- Cancer Research 26
- Pulmonary and Respiratory Medicine 43
- Infectious Diseases 22
Countries citing papers authored by Clémence Basse
This map shows the geographic impact of Clémence Basse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémence Basse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémence Basse more than expected).
Fields of papers citing papers by Clémence Basse
This network shows the impact of papers produced by Clémence Basse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémence Basse. The network helps show where Clémence Basse may publish in the future.
Co-authors
The 25 scholars most cited alongside Clémence Basse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 80 | |
| 2 | 2014 | 73 | |
| 3 | 2022 | 27 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2017 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2018 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2021 | 1 |
About Clémence Basse
Clémence Basse is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Epidemiology and Cancer Research, having authored 27 papers that have together received 270 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Myasthenia Gravis and Thymoma (7 papers), Lung Cancer Research Studies (4 papers), COVID-19 and healthcare impacts (3 papers), Pituitary Gland Disorders and Treatments (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (126 citations), Neurology (47 citations), Cancer Research (26 citations), Pulmonary and Respiratory Medicine (43 citations) and Infectious Diseases (22 citations). Clémence Basse has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Michel Arock, Nicolas Girard, Keith Killian, Jeffrey S. Ross, Shakti Ramkissoon, Xavier Paolettí, Alexa B. Schrock, Laurence Bozec, Youlia Kirova and Paul Cottu. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, Clinical Lung Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.